The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community
Public ClinicalTrials.gov record NCT03120936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03120936
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Public Health Foundation Enterprises, Inc.
- Other
- Enrollment
- 158 participants
Conditions and interventions
Conditions
Interventions
- Emtricitabine / Tenofovir Disoproxil Oral Tablet Drug
- PrEP support Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 7, 2017
- Primary completion
- Aug 26, 2020
- Completion
- Nov 30, 2020
- Last update posted
- Apr 20, 2021
2017 – 2020
United States locations
- U.S. sites
- 5
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tri-City Health Center | Fremont | California | 94538 | — |
| Bridge HIV, San Francisco Department of Public Health | San Francisco | California | 94102 | — |
| Tom Waddell Urban Health Clinic | San Francisco | California | 94102 | — |
| San Francisco Community Health Clinic | San Francisco | California | 94109 | — |
| Castro-Mission Health Center | San Francisco | California | 94114 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03120936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03120936 live on ClinicalTrials.gov.